These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
317 related articles for article (PubMed ID: 36176934)
1. Calbindin S100A16 Promotes Renal Cell Carcinoma Progression and Angiogenesis via the VEGF/VEGFR2 Signaling Pathway. Wang N; Wang R; Tang J; Gao J; Fang Z; Zhang M; Shen X; Lu L; Chen Y Contrast Media Mol Imaging; 2022; 2022():5602011. PubMed ID: 36176934 [TBL] [Abstract][Full Text] [Related]
2. S100A16 Regulates HeLa Cell through the Phosphatidylinositol 3 Kinase (PI3K)/AKT Signaling Pathway. Zhang H; Yang Y; Ma X; Xin W; Fan X Med Sci Monit; 2020 Jan; 26():e919757. PubMed ID: 31894756 [TBL] [Abstract][Full Text] [Related]
3. Tuftelin 1 (TUFT1) Promotes the Proliferation and Migration of Renal Cell Carcinoma Lin H; Zeng W; Lei Y; Chen D; Nie Z Pathol Oncol Res; 2021; 27():640936. PubMed ID: 34257606 [TBL] [Abstract][Full Text] [Related]
4. Infiltrating mast cells promote renal cell carcinoma angiogenesis by modulating PI3K→︀AKT→︀GSK3β→︀AM signaling. Chen Y; Li C; Xie H; Fan Y; Yang Z; Ma J; He D; Li L Oncogene; 2017 May; 36(20):2879-2888. PubMed ID: 28114284 [TBL] [Abstract][Full Text] [Related]
5. Acylglycerol kinase promotes tumour growth and metastasis via activating the PI3K/AKT/GSK3β signalling pathway in renal cell carcinoma. Zhu Q; Zhong AL; Hu H; Zhao JJ; Weng DS; Tang Y; Pan QZ; Zhou ZQ; Song MJ; Yang JY; He JY; Liu Y; Li M; Hu WM; Yang CP; Xiang T; Chen MY; Ma G; Guo L; Xia JC J Hematol Oncol; 2020 Jan; 13(1):2. PubMed ID: 31900208 [TBL] [Abstract][Full Text] [Related]
6. CEP55 promotes epithelial-mesenchymal transition in renal cell carcinoma through PI3K/AKT/mTOR pathway. Chen H; Zhu D; Zheng Z; Cai Y; Chen Z; Xie W Clin Transl Oncol; 2019 Jul; 21(7):939-949. PubMed ID: 30607788 [TBL] [Abstract][Full Text] [Related]
7. miRNA‑205‑5p functions as a tumor suppressor by negatively regulating VEGFA and PI3K/Akt/mTOR signaling in renal carcinoma cells. Huang J; Wang X; Wen G; Ren Y Oncol Rep; 2019 Nov; 42(5):1677-1688. PubMed ID: 31545453 [TBL] [Abstract][Full Text] [Related]
8. TAGLN2 Promotes the Proliferation, Migration, Invasion, and EMT of Clear Cell Renal Cell Carcinoma Through the PI3K/Akt Signaling Pathway. He Y; Zhang B; Han D; Du Y; Zhang X; Wang H; Yue Z; Shang P Biochem Genet; 2023 Aug; 61(4):1265-1281. PubMed ID: 36547768 [TBL] [Abstract][Full Text] [Related]
9. Fc receptor-like A promotes malignant behavior in renal cell carcinoma and correlates with tumor immune infiltration. Liu JP; Jiang YF; Liu JW; Tian CJ; Lin YZ; Yang YZ; Zhang ZK; Fang YL; Huang B; Lin H Cancer Med; 2024 Aug; 13(15):e70072. PubMed ID: 39108036 [TBL] [Abstract][Full Text] [Related]
10. Glutathione peroxidase family and survival prognosis in patients with renal cell carcinoma. Li J; Huo S; Zhang R; Shi C; Sun N; Liu Q Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 May; 47(5):562-572. PubMed ID: 35753726 [TBL] [Abstract][Full Text] [Related]
11. UBE2T promotes proliferation and regulates PI3K/Akt signaling in renal cell carcinoma. Hao P; Kang B; Li Y; Hao W; Ma F Mol Med Rep; 2019 Aug; 20(2):1212-1220. PubMed ID: 31173226 [TBL] [Abstract][Full Text] [Related]
12. Lipid metabolism-related gene expression in the immune microenvironment predicts prognostic outcomes in renal cell carcinoma. Zhang Q; Lin B; Chen H; Ye Y; Huang Y; Chen Z; Li J Front Immunol; 2023; 14():1324205. PubMed ID: 38090559 [TBL] [Abstract][Full Text] [Related]
13. RHBDD1 promotes proliferation, migration, invasion and EMT in renal cell carcinoma via the EGFR/AKT signaling pathway. Li M; Cai L; Wang X; Yu Y; Jian W; Bao G; Gao Z; Guo J; Zhang J; Li C; Zhang C Mol Med Rep; 2021 Dec; 24(6):. PubMed ID: 34581421 [TBL] [Abstract][Full Text] [Related]
14. Decreased expression of CHIP leads to increased angiogenesis via VEGF-VEGFR2 pathway and poor prognosis in human renal cell carcinoma. Sun C; Li HL; Chen HR; Shi ML; Liu QH; Pan ZQ; Bai J; Zheng JN Sci Rep; 2015 May; 5():9774. PubMed ID: 26021863 [TBL] [Abstract][Full Text] [Related]
15. Long non-coding RNA HOTTIP affects renal cell carcinoma progression by regulating autophagy via the PI3K/Akt/Atg13 signaling pathway. Su Y; Lu J; Chen X; Liang C; Luo P; Qin C; Zhang J J Cancer Res Clin Oncol; 2019 Mar; 145(3):573-588. PubMed ID: 30511250 [TBL] [Abstract][Full Text] [Related]
16. Glycolysis-related gene dihydrolipoamide acetyltransferase promotes poor prognosis in hepatocellular carcinoma through the Wnt/β-catenin and PI3K/Akt signaling pathways. Zhou Y; Gu H; Shao B; Zhang S; Pall H; Peixoto RD; Mok SRS; Zhu G Ann Transl Med; 2022 Nov; 10(22):1240. PubMed ID: 36544660 [TBL] [Abstract][Full Text] [Related]
17. MicroRNA‑218 inhibits tumor angiogenesis of human renal cell carcinoma by targeting GAB2. Mu L; Guan B; Tian J; Li X; Long Q; Wang M; Wang W; She J; Li X; Wu D; Du Y Oncol Rep; 2020 Nov; 44(5):1961-1970. PubMed ID: 32901879 [TBL] [Abstract][Full Text] [Related]
18. Ghrelin promotes renal cell carcinoma metastasis via Snail activation and is associated with poor prognosis. Lin TC; Liu YP; Chan YC; Su CY; Lin YF; Hsu SL; Yang CS; Hsiao M J Pathol; 2015 Sep; 237(1):50-61. PubMed ID: 25925728 [TBL] [Abstract][Full Text] [Related]
19. Caveolin-1 in renal cell carcinoma promotes tumour cell invasion, and in co-operation with pERK predicts metastases in patients with clinically confined disease. Campbell L; Al-Jayyoussi G; Gutteridge R; Gumbleton N; Griffiths R; Gumbleton S; Smith MW; Griffiths DF; Gumbleton M J Transl Med; 2013 Oct; 11():255. PubMed ID: 24119769 [TBL] [Abstract][Full Text] [Related]
20. Polycystin-1 induces activation of the PI3K/AKT/mTOR pathway and promotes angiogenesis in renal cell carcinoma. Gargalionis AN; Sarlani E; Stofas A; Malakou LS; Adamopoulos C; Bamias A; Boutati E; Constantinides CA; Stravodimos KG; Piperi C; Papavassiliou AG; Korkolopoulou P Cancer Lett; 2020 Oct; 489():135-143. PubMed ID: 32561414 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]